These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21179616)

  • 21. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
    Jellinger KA; Seppi K; Wenning GK
    Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic trial design issues for future disease-modifying therapy of multiple system atrophy].
    Ichikawa Y; Goto J; Nakahara Y; Mitsui J; Tsuji S
    Rinsho Shinkeigaku; 2011 Nov; 51(11):910-3. PubMed ID: 22277413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MSA: From basic mechanisms to experimental therapeutics.
    Heras-Garvin A; Stefanova N
    Parkinsonism Relat Disord; 2020 Apr; 73():94-104. PubMed ID: 32005598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinsonism. Multiple system atrophy.
    Wenning GK; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):187-204. PubMed ID: 9426875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal models of multiple system atrophy.
    Stefanova N; Tison F; Reindl M; Poewe W; Wenning GK
    Trends Neurosci; 2005 Sep; 28(9):501-6. PubMed ID: 16043239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.
    Gilman S; Low P; Quinn N; Albanese A; Ben-Shlomo Y; Fowler C; Kaufmann H; Klockgether T; Lang A; Lantos P; Litvan I; Mathias C; Oliver E; Robertson D; Schatz I; Wenning G
    Clin Auton Res; 1998 Dec; 8(6):359-62. PubMed ID: 9869555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple system atrophy.
    Wenning GK; Krismer F
    Handb Clin Neurol; 2013; 117():229-41. PubMed ID: 24095129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple System Atrophy - Cerebellar Type: Clinical Picture and Treatment of an Often-Overlooked Disorder.
    Ortiz JF; Betté S; Tambo W; Tao F; Cozar JC; Isaacson S
    Cureus; 2020 Sep; 12(9):e10741. PubMed ID: 33173654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future treatments in multiple system atrophy.
    Esper CD; Factor SA
    Curr Treat Options Neurol; 2007 May; 9(3):210-23. PubMed ID: 17445499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in clinical diagnostic criteria for multiple system atrophy].
    Tison F
    Rev Neurol (Paris); 2000 Sep; 156(8-9):711-7. PubMed ID: 10992115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple system atrophy.
    Fanciulli A; Stankovic I; Krismer F; Seppi K; Levin J; Wenning GK
    Int Rev Neurobiol; 2019; 149():137-192. PubMed ID: 31779811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ; Hermann KL; Schmahmann JD
    Cerebellum; 2016 Dec; 15(6):663-679. PubMed ID: 26467153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple System Atrophy - State of the Art.
    Laurens B; Vergnet S; Lopez MC; Foubert-Samier A; Tison F; Fernagut PO; Meissner WG
    Curr Neurol Neurosci Rep; 2017 May; 17(5):41. PubMed ID: 28378233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple system atrophy.
    Wenning GK; Colosimo C; Geser F; Poewe W
    Lancet Neurol; 2004 Feb; 3(2):93-103. PubMed ID: 14747001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.
    Herrera-Vaquero M; Bouquio D; Kallab M; Biggs K; Nair G; Ochoa J; Heras-Garvin A; Heid C; Hadrovic I; Poewe W; Wenning GK; Klärner FG; Schrader T; Bitan G; Stefanova N
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165513. PubMed ID: 31319154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo models of multiple system atrophy.
    Fernagut PO; Ghorayeb I; Diguet E; Tison F
    Mov Disord; 2005 Aug; 20 Suppl 12():S57-63. PubMed ID: 16092092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Towards more efficient clinical trials for multiple system atrophy in Japan].
    Ichikawa Y
    Brain Nerve; 2012 Oct; 64(10):1141-9. PubMed ID: 23037604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic strategies in multiple system atrophy.
    Wenning GK; Geser F; Poewe W
    Mov Disord; 2005 Aug; 20 Suppl 12():S67-76. PubMed ID: 16092094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse model of adult-onset multiple system atrophy.
    Tanji K; Miki Y; Mori F; Nikaido Y; Narita H; Kakita A; Takahashi H; Wakabayashi K
    Neurobiol Dis; 2019 Jul; 127():339-349. PubMed ID: 30910745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.